Documents & Downloads

Vortosiran

Factor XI synthesis reducer

Vortosiran is a small interfering RNA (siRNA) that targets and reduces the synthesis of coagulation factor XI, thereby exerting anticoagulant effects. This compound has potential applications in the study of thrombotic disorders and the development of novel anticoagulant therapies. Vortosiran can be utilized in research settings to explore the modulation of coagulation pathways and the impact of factor XI on thrombosis.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	3061406-99-0
Applications	Factor XI synthesis reducer
Formula	C₄₆₃H₆₂₀F₇N₁₅₄O₂₉₁P₃₉S₆
Molecular Weight	14532.10

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.